Content Block Tag: NRG-CC008: Ovarian Cancer Risk Reduction
‘Text/HTML’ of page ‘NRG-CC008: Ovarian Cancer Risk Reduction’
Quick Information Find a study location Are you interested in joining this study? Find a Participating Location Want more information? Additional information for the NRG-CC008 ‘SOROCk’ trial can be found in the Patient Study Brochure Download Brochure
Read More
‘Text/HTML’ of page ‘NRG-CC008: Ovarian Cancer Risk Reduction’
Frequently Asked Questions Below, you can find FAQs about clinical research and this particular clinical trial.
Read More
‘Text/HTML’ of page ‘NRG-CC008: Ovarian Cancer Risk Reduction’
Am I eligible for this study? Individuals may be able to participate if they are premenopausal, between the ages of 35 and 50, and have an inherited BRCA1 mutation and are planning to have surgery to reduce their risk of ovarian cancer. Are there other studies for which I might be eligible? Please talk to […]
Read More
‘Text/HTML’ of page ‘NRG-CC008: Ovarian Cancer Risk Reduction’
About This Study NRG-CC008, also known as the SOROCk Trial, is a clinical trial available to a particular group of individuals with inherited BRCA1 mutations. For these pre-menopausal individuals, the study is testing whether removal of just the fallopian tubes, with the plan to remove the ovaries at a later time, can reduce the […]
Read More
‘Text/HTML’ of page ‘NRG-CC008: Ovarian Cancer Risk Reduction’
Clinical Studies FAQ
Read More
‘Text/HTML’ of page ‘NRG-CC008: Ovarian Cancer Risk Reduction’
NRG-CC008 (SOROCk) FAQ
Read More